Pinnacle Summer Investments’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$306K Sell
4,505
-16,455
-79% -$1.08M 0.05% 172
2015
Q3
$1.33M Buy
+20,960
New +$1.38M 0.23% 89
2015
Q2
Sell
-21,645
Closed -$1.48M 746
2015
Q1
$1.48M Sell
21,645
-1,165
-5% -$80.9K 0.2% 90
2014
Q4
$1.6M Sell
22,810
-290
-1% -$20.8K 0.2% 87
2014
Q3
$1.65M Sell
23,100
-725
-3% -$53.1K 0.18% 86
2014
Q2
$1.77M Buy
23,825
+350
+1% +$25.3K 0.21% 76
2014
Q1
$1.86M Sell
23,475
-350
-1% -$22.6K 0.23% 59
2013
Q4
$1.41M Buy
23,825
+735
+3% +$39.9K 0.19% 81
2013
Q3
$1.2M Buy
23,090
+1,930
+9% +$96.9K 0.21% 83
2013
Q2
$1M Buy
+21,160
New +$1.08M 0.25% 72

Other funds holding AZN

Pinnacle Summer Investments's AZN Position: Q4 2015 in Review

Pinnacle Summer Investments reduced its AstraZeneca (AZN) stake by 79% in Q4 2015, selling an estimated $1.08M and leaving 4,505 shares worth $306K. The position accounts for 0.05% of the portfolio, ranked #172.

Pinnacle Summer Investments first reported a position in AZN in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.86M in Q1 2014. 390 funds tracked by Wall St. Rank hold AZN as of Q4 2015.

  • Pinnacle Summer Investments held 4,505 shares of AstraZeneca worth $306K as of Q4 2015.
  • Pinnacle Summer Investments sold 16,455 AstraZeneca shares in Q4 2015, an estimated $1.08M.
  • AstraZeneca made up 0.05% of Pinnacle Summer Investments's portfolio in Q4 2015, its #172 holding.
  • Pinnacle Summer Investments first reported a position in AstraZeneca in Q2 2013 and has held it in 10 quarters since.
  • Pinnacle Summer Investments's AstraZeneca position peaked at $1.86M in Q1 2014.
  • 390 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2015.

Based on Pinnacle Summer Investments's 13F filing for Q4 2015, filed 16 Feb 2016.